News

A team led by Ari Melnick, M.D., has found that a genetic mutation implicated in a common and incurable form of non-Hodgkin lymphoma drives disease development by disrupting the mechanism that manages normal immune cell growth. Read more

Watchful waiting or active treatment? Jim Hu, M.D., has studied surveillance strategies among patients diagnosed with localized prostate cancer. Read more

Profile of the new chief of liver transplantation and hepatobiliary surgery, Benjamin Samstein, M.D. Read more

Heather Yeo, M.D., writes a guest blog post about areas where mobile technologies have the potential to benefit patients and physicians. Read more

Jim Hu, M.D., discusses the need to assess functional and survival outcomes of robotic surgery among prostate cancer patients. Read more

A retrospective study of pediatric brain tumors by Jeffrey Greenfield, M.D., has found gender differences in survival outcomes. Read more

Heather Yeo, M.D., comments on a study about a combination treatment option for patients with locally advanced rectal cancer. Read more

Mark Rubin, M.D., will lead an investigation into the genomics of prostate cancer progression. Read more

Treating terminally ill cancer patients with chemotherapy in the months or weeks before their deaths was not found to improve patients' quality of life and may actually do more harm than good, according to a new study led by Holly Prigerson, Ph.D. Read more